| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Cephalexin impurity 3 |
头孢氨苄杂质 3 |
|
详细
|
| Pramipexole Related Impurity 2 |
普拉克索杂质标准品 |
|
详细
|
| Moxifloxacin impurities |
莫西沙星系列杂质 |
|
详细
|
| Moxifloxacin impurities |
莫西沙星杂质 |
1394029-14-1 |
详细
|
| Formyl ciprofloxacin |
甲酰环丙沙星杂质 |
93594-39-9 |
详细
|
| Amifostine impurity3 |
氨磷汀杂质3 |
|
详细
|
| (S)-2,2'-(2-methyl-6-oxopiperazine-1,4-diyl)diacetic acid |
右雷佐生杂质21 |
|
详细
|
| ethyl 2-formyl-3-oxo-3-(2,4,5-trifluoro-3-methoxyphenyl)propanoate |
莫西沙星杂质JX |
|
详细
|
| Amifostine impurity 1 |
氨磷汀杂质1 |
|
详细
|
| Gadobutrol Impurity 4 |
钆布醇杂质4 |
|
详细
|
| Gadobutrol Impurity 3 |
钆布醇杂质3 |
|
详细
|
| Cediranib |
西地尼布 |
288383-20-0 |
详细
|
| Levofloxacin, chloromethyl ester impurity |
左氧氟沙星氯代甲酯杂质 |
|
详细
|
| Poziotinib |
波齐替尼 |
1092364-38-9 |
详细
|
| Afatinib |
阿法替尼(BIBW 2992) |
439081-18-2 |
详细
|
| Cabozantinib Malate |
苹果酸卡博替尼（CABOZANTINIB S-MALATE） |
1140909-48-3 |
详细
|
| regorafenib |
瑞格非尼 |
755037-03-7 |
详细
|
| Crizotinib |
克唑替尼 |
877399-52-5 |
详细
|
| Cediranib Maleate |
西地尼布马来酸盐 |
857036-77-2 |
详细
|
| Cephalexin impurity 5 |
头孢氨苄杂质 5 |
1323247-65-9 |
详细
|
| Cephalexin S-Sulfoxide |
CEPHALEXIN S-SULFOXIDE |
74708-55-7 |
详细
|
| Cephalexin 7-Epimer |
头孢氨苄 7-差向异构体 |
|
详细
|
| Cephalexin impurity 6 |
头孢氨苄杂质 6 |
72820-16-7 |
详细
|
| Cephalexin impurity L |
头孢氨苄杂质 L |
34632-04-7 |
详细
|
| Cephalexin R-Sulfoxide |
苯甘孢霉素亚砜 |
52210-38-5 |
详细
|
| Lauratinib |
劳拉替尼（PF0643922） |
1454846-35-5 |
详细
|
| Pramipexole Related Impurity 1 |
普拉克索二聚体杂质 |
1244656-98-1 |
详细
|
| Entrectinib |
恩曲替尼 |
1108743-60-7 |
详细
|
| Moxifloxacin Impurity 45 |
莫西沙星杂质45 |
|
详细
|
| Niraparib tosylate |
尼拉帕尼对甲苯磺酸盐 |
1613220-15-7 |
详细
|
| Finasteride |
非那雄胺 |
98319-26-7 |
详细
|
| Bosutinib |
博舒替尼 |
380843-75-4 |
详细
|
| Vandetanib |
凡德他尼 |
443913-73-3 |
详细
|
| AZD3759 |
奥希替尼 |
1626387-80-1 |
详细
|
| alectinib |
艾乐替尼 |
1256580-46-7 |
详细
|
| axitinib |
阿昔替尼 |
319460-85-0 |
详细
|
| Olaparib |
奥拉帕尼 |
763113-22-0 |
详细
|
| 2-(2-NAPHTHYLOXY)ETHANAMINE |
2-(2-萘氧基)乙胺 |
23314-24-1 |
详细
|
| 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-diazinane-2,4,6-trione |
6-氧代-5,6-二氢尿苷 |
19556-63-9 |
详细
|
| ThiametGDiscontinued |
THIAMET G |
1009816-48-1 |
详细
|
| SB204741 |
SB 204741 |
152239-46-8 |
详细
|
| 1,3,4,6-Tetra-O-acetyl-2-amino-2-deoxy-a-D-glucopyranoseHydrochloride |
1,3,4,6-四-O-乙酰基-2-氨基-ALPHA-D-吡喃葡萄糖盐酸盐 |
10034-19-2 |
详细
|
| treosulfan |
曲奥舒凡 |
299-75-2 |
详细
|
| Geranyl |
(2R,3R,4S,5S,6R)-2-[(2E)-3,7-二甲基辛-2,6-二烯氧基]-6-[[(2S,3R,4S,5R)-3,4,5-三羟基四氢吡喃-2-基]氧基甲基]四氢吡喃-3,4,5-三醇 |
150995-11-2 |
详细
|
| 3,4-DI-O-ACETYL-6-DEOXY-L-GLUCAL |
二-O-乙酰基-L-鼠李醛 |
34819-86-8 |
详细
|
| 9-ALPHA-RIBOFURANOSYLADENINE |
ALPHA-腺苷 |
5682-25-7 |
详细
|
| 2-Acetamido-1,3,4,6-tetra-O-acetyl-2-deoxy-b-D-galactopyranose |
Β-D-氨基半乳糖五乙酸酯 |
3006-60-8 |
详细
|
| 2-(Acetylamino)-2-deoxy-1-thio-alpha-D-glucopyranose |
2-(乙酰氨基)-2-脱氧-1-硫代-ALPHA-D-吡喃葡萄糖 |
781581-10-0 |
详细
|
| Trametinib |
曲美替尼 |
871700-17-3 |
详细
|
| lenvatinib Mesylate |
乐伐替尼 |
857890-39-2 |
详细
|
| CapMatinib |
苯扎米特 |
1029712-80-8 |
详细
|
| Nintedanib Ethanesulfonate Salt |
尼达尼布乙磺酸盐 |
656247-18-6 |
详细
|
| INCB28060 |
苯扎米特盐酸盐 |
1197376-85-4 |
详细
|
| Neratinib |
来那替尼 |
698387-09-6 |
详细
|
| LOXO-101 |
拉罗替尼 |
1223405-08-0 |
详细
|
| Regorafenib hydrate |
瑞格非尼一水合物 |
1019206-88-2 |
详细
|
| Pazopanib |
帕唑帕尼 |
444731-52-6 |
详细
|
| Upadacitinib |
乌帕替尼 |
1310726-60-3 |
详细
|
| Selumetinib |
司美替尼 |
606143-52-6 |
详细
|
| Brigatinib |
布格替尼 |
1197953-54-0 |
详细
|
| Dabrafenib |
达帕菲尼 |
1195765-45-7 |
详细
|
| Dacomitinib |
达克替尼 |
1110813-31-4 |
详细
|
| Prostaglandin E1 |
前列腺素E1 |
745-65-3 |
详细
|
| Bimatoprost |
比马前列素 |
155206-00-1 |
详细
|
| AP 32788 |
莫博替尼 |
1847461-43-1 |
详细
|
| Pramipexole Impurity 22 |
普拉克索杂质22 |
|
详细
|
| Pramipexole Impurity 16 |
普拉克索杂质16 |
1373869-91-0 |
详细
|
| rac-7-Oxo-Pramipexole HCl |
普拉克索杂质29 |
1286047-33-3 |
详细
|
| Decarboxy Moxifloxacin |
脱羧酸莫西沙星 |
929102-25-0 |
详细
|
| (2S,4S)-Argatroban |
(2S,4S)-阿加曲班 |
189264-03-7 |
详细
|
| 7(4H)-Benzothiazolone, 2-amino-5,6-dihydro-6-(propylamino)-, (6S)- |
普拉克索杂质 |
2204518-89-6 |
详细
|
| Benazepril Related Compound F |
贝那普利杂质F |
109010-60-8 |
详细
|
| Nicorandil EP Impurity C |
尼可地尔杂质C |
88598-33-8 |
详细
|
| Benazepril impurity |
贝那普利杂质 |
1347874-67-2 |
详细
|
| Nicorandil EP Impurity D |
尼可地尔杂质D |
40055-37-6 |
详细
|
| Dibucaine Impurity C |
辛可卡因EP杂质C |
87864-08-2 |
详细
|
| Nicorandil EP Impurity A |
尼可地尔EP杂质A |
65141-47-1 |
详细
|
| Nicorandil EP Impurity B |
尼可地尔EP杂质B |
6265-73-2 |
详细
|
| Nicorandil Impurity 6 |
尼可地尔杂质6 |
|
详细
|
| Nicorandil Dimer Bromide |
尼可地尔二聚体 |
2250142-73-3 |
详细
|
| Amifostine impurity2 |
氨磷汀杂质2 |
6305-56-2 |
详细
|
| 3-[(2-Hydroxyethyl)amino]propiononitrile |
氨磷汀杂质4 |
33759-44-3 |
详细
|
| N-(5-(3-(2-ethoxyphenyl)-3-oxopropanoyl)-1-methyl-3-propyl-1H-pyrazol-4-yl)-2-hydroxybenzamide |
西地那非杂质36 |
|
详细
|
| R- Dexrazoxane |
R-右雷佐生 |
24613-06-7 |
详细
|
| Gadobutrol Impurity 2 |
钆布醇杂质2 |
|
详细
|
| Gadobutrol Impurity 5 |
钆布醇杂质5 |
114873-37-9 |
详细
|
| gadolinium(III) 2,2',2''-(1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetat |
钆布醇杂质32 |
|
详细
|
| (3S,4S)-2-Oxa-8-azaspiro[4.5]decan-4-amine, 3-methyl-, hydrochloride (1:2) |
(3S,4S)-3-甲基-2-氧杂-8-氮杂螺[4.5]癸-4-胺二盐酸盐 |
2055761-19-6 |
详细
|
| ectoine |
四氢嘧啶 |
96702-03-3 |
详细
|
| 2-Pyrazinemethanol |
RMC-4550 |
2172651-73-7 |
详细
|
| (3S,4S)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine 2,2,2-trifluoroacetate |
(3S,4S)-8-(6-氨基-5-((2-氨基-3-氯吡啶基-4-基)硫代)吡嗪-2-基)-3-甲基-2-氧杂-8-氮杂螺[4.5]癸-4-胺 |
1801765-04-7 |
详细
|
| Gadobutrol Impurity 23 |
钆布醇杂质23 |
|
详细
|
| Gadobutrol Impurity 11 |
钆布醇杂质11 |
|
详细
|
| 4-(hydroxyamino)-N-(2-(naphthalen-2-yloxy)ethyl)-N- ((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl) benzenesulfonamide |
N-BETA-D-吡喃葡萄糖基-4-(羟基氨基)-N-[2-(2-萘基氧基)乙基]-苯磺酰胺 |
188480-51-5 |
详细
|
| (2-chloro-5-iodophenyl)(2-ethoxyphenyl)methanone |
达格列净杂质8 |
2305949-33-9 |
详细
|
| 1-chloro-2-(2-ethoxybenzyl)-4-iodobenzene |
达格列净杂质9 |
2305949-36-2 |
详细
|
| ethyl 3-oxo-3-(2,4,5-trifluoro-3-methoxyphenyl)propanoate |
莫西沙星SM2杂质 |
112811-68-4 |
详细
|
| ((Z)-ethyl 3-ethoxy-2-(2,4,5-trifluoro-3-methoxybenzoyl)acrylate) |
莫西沙星杂质Ⅳ |
866954-86-1 |
详细
|
| α-L-galactose |
L-(-)-半乳糖 |
15572-79-9 |
详细
|